Human tumor virus utilizes exosomes for intercellular communication
暂无分享,去创建一个
N. Raab-Traub | D. Meckes | R. Edwards | Nancy Raab-Traub | Che-Pei Kung | David G. Meckes | Kathy H. Y. Shair | Aron R. Marquitz | Che-Pei Kung | Rachel H. Edwards | K. H. Shair
[1] G. Raposo,et al. Lipid raft-associated protein sorting in exosomes. , 2003, Blood.
[2] Hamid Cheshmi. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers , 2011 .
[3] Graça Raposo,et al. Exosomes--vesicular carriers for intercellular communication. , 2009, Current opinion in cell biology.
[4] H. Sato,et al. Novel transcription from the Epstein-Barr virus terminal EcoRI fragment, DIJhet, in a nasopharyngeal carcinoma , 1990, Journal of virology.
[5] Qinxi Li,et al. Axin determines cell fate by controlling the p53 activation threshold after DNA damage , 2009, Nature Cell Biology.
[6] N. Raab-Traub,et al. Epstein-Barr Virus BART MicroRNAs Are Produced from a Large Intron prior to Splicing , 2008, Journal of Virology.
[7] N. Raab-Traub,et al. Unique Signaling Properties of CTAR1 in LMP1-Mediated Transformation , 2007, Journal of Virology.
[8] N. Raab-Traub,et al. Epstein-Barr Virus Latent Membrane Protein 1 Induces Expression of the Epidermal Growth Factor Receptor through Effects on Bcl-3 and STAT3 , 2008, Journal of Virology.
[9] Johan Skog,et al. Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.
[10] Mhairi A. Morris,et al. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. , 2009, Future oncology.
[11] R. Simpson,et al. Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.
[12] M. Koike,et al. Human Herpesvirus-6 Induces MVB Formation, and Virus Egress Occurs by an Exosomal Release Pathway , 2008, Traffic.
[13] E. Kieff,et al. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.
[14] J. Lötvall,et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells , 2007, Nature Cell Biology.
[15] K. Burns,et al. Ubiquitination of the Epstein–Barr virus-encoded latent membrane protein 1 depends on the integrity of the TRAF binding site , 2003, Oncogene.
[16] Y. Shimizu,et al. A New Diagnostic Marker for Secreted Epstein-Barr Virus–Encoded LMP1 and BARF1 Oncoproteins in the Serum and Saliva of Patients with Nasopharyngeal Carcinoma , 2007, Clinical Cancer Research.
[17] Sanchita Bhatnagar,et al. Exosome Function: From Tumor Immunology to Pathogen Biology , 2008, Traffic.
[18] S. Ceccarelli,et al. Epstein‐Barr virus latent membrane protein 1 promotes concentration in multivesicular bodies of fibroblast growth factor 2 and its release through exosomes , 2007, International journal of cancer.
[19] N. Raab-Traub,et al. EBV latent membrane protein 1 effects on plakoglobin, cell growth, and migration. , 2008, Cancer research.
[20] J. Slot,et al. Proteomic and Biochemical Analyses of Human B Cell-derived Exosomes , 2003, The Journal of Biological Chemistry.
[21] E. Kieff,et al. Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[22] T. Niki,et al. Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells. , 2009, Blood.
[23] T. D. de Gruijl,et al. Functional delivery of viral miRNAs via exosomes , 2010, Proceedings of the National Academy of Sciences.
[24] S. Cheung,et al. Nasopharyngeal carcinoma cell line (C666‐1) consistently harbouring Epstein‐Barr virus , 1999, International journal of cancer.
[25] W. Miller,et al. The Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor , 1995, Journal of virology.
[26] E. Kieff,et al. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[27] R. Kerbel,et al. Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR , 2009, Proceedings of the National Academy of Sciences.
[28] P. Altevogt,et al. Systemic presence and tumor-growth promoting effect of ovarian carcinoma released exosomes. , 2009, Cancer letters.
[29] F. Hanisch,et al. Proteomics of MUC1‐containing lipid rafts from plasma membranes and exosomes of human breast carcinoma cells MCF‐7 , 2009, Proteomics.
[30] W. Miller,et al. The EGFR as a target for viral oncoproteins. , 1999, Trends in microbiology.
[31] M. Hirashima,et al. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9 , 2006, BMC Cancer.
[32] Alexandra Schäfer,et al. Epstein–Barr Virus MicroRNAs Are Evolutionarily Conserved and Differentially Expressed , 2006, PLoS pathogens.
[33] Samuel A Wickline,et al. Paracrine induction of endothelium by tumor exosomes , 2009, Laboratory Investigation.
[34] N. Raab-Traub. Epstein-Barr virus in the pathogenesis of NPC. , 2002, Seminars in cancer biology.
[35] E. Bloemena,et al. Direct Immunosuppressive Effects of EBV-Encoded Latent Membrane Protein 1 , 2000, The Journal of Immunology.
[36] Mark Marsh,et al. Virus Entry: Open Sesame , 2006, Cell.
[37] W. Miller,et al. TRAF interactions with raft‐like buoyant complexes, better than TRAF rates of degradation, differentiate signaling by CD40 and EBV latent membrane protein 1 , 2005, International journal of cancer.
[38] A. Tsun,et al. The immunological synapse: a focal point for endocytosis and exocytosis , 2010, The Journal of cell biology.
[39] J. Hurley,et al. ESCRT complexes and the biogenesis of multivesicular bodies. , 2008, Current opinion in cell biology.